SCHEMBL21046008

SCHEMBL21046008

CCCCCCCOCC(CO)CO

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 1/20 0.68
HTT P42858 2/20 0.55
MEN1 O00255 1/20 0.54
THRB P10828 1/20 0.54
KMT2A Q03164 1/20 0.54
MAPT P10636 1/20 0.54
LMNA P02545 1/20 0.52
SPHK1 Q9NYA1 1/20 0.50
LPAR1 Q92633 7/20 0.47
LPAR3 Q9UBY5 7/20 0.47
LPAR5 Q9H1C0 4/20 0.47
LPAR2 Q9HBW0 4/20 0.47
LPAR6 P43657 3/20 0.47
LPAR4 Q99677 3/20 0.47
PLA2G2C Q5R387 2/20 0.46
CES2 O00748 1/20 0.45
PRKD3 O94806 1/20 0.44
PRKCG P05129 1/20 0.44
PRKCB P05771 1/20 0.44
PRKCA P17252 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21046018 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL21046022 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL16367888 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL21046013 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL21046030 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL21046040 1.00 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL20898306 0.96 USP2 (0.68) USP2HTTMEN1THRBKMT2A
SCHEMBL20898182 0.93 USP2 (0.64) USP2HTTMEN1THRBKMT2A
SCHEMBL22287251 0.92 USP2 (0.63) USP2HTTMEN1THRBKMT2A
SCHEMBL19821307 0.92 USP2 (0.63) USP2HTTMEN1THRBKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190169218-A1 AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS (KR) 2019-06-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190169218-A1 AMPHIPATHIC COMPOUND HAVING NOVEL PENTA-SACCHARIDE HYDROPHILIC GROUP AND USE THEREOF UGCG, APMAP, GID4 USP2 3446/4885HTT 2033/4885MEN1 4013/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.